PF
SNDX icon

Phoenix Financial’s Syndax Pharmaceuticals SNDX Stock Holding History

Phoenix Financial’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-31,740
Closed -$489K – 496
2025
Q3 		$489K Sell
31,740
-43,223
-58% -$566K 0.01% 302
2025
Q2 		$701K Buy
+74,963
New +$825K 0.01% 261
2022
Q3 		– Sell
-525,856
Closed -$10.1M – 365
2022
Q2 		$10.1M Hold
525,856
– – 0.21% 79
2022
Q1 		$9.14M Buy
525,856
+183,500
+54% +$3.09M 0.15% 105
2021
Q4 		$7.49M Buy
342,356
+132,356
+63% +$2.45M 0.12% 111
2021
Q3 		$4.01M Buy
210,000
+100,000
+91% +$1.67M 0.07% 155
2021
Q2 		$1.89M Buy
+110,000
New +$2.01M 0.04% 218

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Phoenix Financial's SNDX Position: Q4 2025 in Review

Phoenix Financial sold out of Syndax Pharmaceuticals (SNDX) in Q4 2025, closing a stake of 31,740 shares — an estimated $489K sold.

Phoenix Financial first reported a position in SNDX in Q2 2021 and held it in 7 quarters. The position peaked at $10.1M in Q2 2022. 230 funds tracked by Wall St. Rank hold SNDX as of Q4 2025.

  • Phoenix Financial reported no remaining Syndax Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Phoenix Financial sold 31,740 Syndax Pharmaceuticals shares in Q4 2025, an estimated $489K.
  • Phoenix Financial first reported a position in Syndax Pharmaceuticals in Q2 2021 and held it in 7 quarters.
  • Phoenix Financial's Syndax Pharmaceuticals position peaked at $10.1M in Q2 2022.
  • 230 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2025.

Based on Phoenix Financial's 13F filing for Q4 2025, filed 5 Feb 2026.